- KR₩943bn
- KR₩930bn
- KR₩711bn
Annual balance sheet for SD Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,779,821 | 2,069,971 | 557,717 | 384,250 | 688,757 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 391,486 | 118,002 | 153,160 | 171,419 | 174,909 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,606,788 | 2,517,266 | 964,970 | 938,393 | 1,232,814 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 207,128 | 468,635 | 551,500 | 485,610 | 439,487 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,033,933 | 3,261,922 | 3,788,831 | 3,888,464 | 3,242,720 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 779,869 | 296,980 | 320,758 | 176,564 | 466,251 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 814,582 | 317,621 | 965,171 | 965,130 | 913,038 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,219,351 | 2,944,301 | 2,823,660 | 2,923,334 | 2,329,681 |
| Total Liabilities & Shareholders' Equity | 3,033,933 | 3,261,922 | 3,788,831 | 3,888,464 | 3,242,720 |
| Total Common Shares Outstanding |